Experimental Models of COVID-19
- PMID: 35096645
- PMCID: PMC8791197
- DOI: 10.3389/fcimb.2021.792584
Experimental Models of COVID-19
Abstract
COVID-19 is the most consequential pandemic of the 21st century. Since the earliest stage of the 2019-2020 epidemic, animal models have been useful in understanding the etiopathogenesis of SARS-CoV-2 infection and rapid development of vaccines/drugs to prevent, treat or eradicate SARS-CoV-2 infection. Early SARS-CoV-1 research using immortalized in-vitro cell lines have aided in understanding different cells and receptors needed for SARS-CoV-2 infection and, due to their ability to be easily manipulated, continue to broaden our understanding of COVID-19 disease in in-vivo models. The scientific community determined animal models as the most useful models which could demonstrate viral infection, replication, transmission, and spectrum of illness as seen in human populations. Until now, there have not been well-described animal models of SARS-CoV-2 infection although transgenic mouse models (i.e. mice with humanized ACE2 receptors with humanized receptors) have been proposed. Additionally, there are only limited facilities (Biosafety level 3 laboratories) available to contribute research to aid in eventually exterminating SARS-CoV-2 infection around the world. This review summarizes the most successful animal models of SARS-CoV-2 infection including studies in Non-Human Primates (NHPs) which were found to be susceptible to infection and transmitted the virus similarly to humans (e.g., Rhesus macaques, Cynomolgus, and African Green Monkeys), and animal models that do not require Biosafety level 3 laboratories (e.g., Mouse Hepatitis Virus models of COVID-19, Ferret model, Syrian Hamster model). Balancing safety, mimicking human COVID-19 and robustness of the animal model, the Murine Hepatitis Virus-1 Murine model currently represents the most optimal model for SARS-CoV-2/COVID19 research. Exploring future animal models will aid researchers/scientists in discovering the mechanisms of SARS-CoV-2 infection and in identifying therapies to prevent or treat COVID-19.
Keywords: COVID-19; MHV-1; SARS-CoV-2; experimental models of COVID-19; in vitro model; pathology; pneumonia; variants of concern.
Copyright © 2022 Caldera-Crespo, Paidas, Roy, Schulman, Kenyon, Daunert and Jayakumar.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8791197/bin/fcimb-11-792584-g009.gif)
Similar articles
-
Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis.ILAR J. 2021 Dec 31;62(1-2):35-47. doi: 10.1093/ilar/ilab007. ILAR J. 2021. PMID: 33836527 Free PMC article.
-
A Meta-Analysis of Rhesus Macaques (Macaca mulatta), Cynomolgus Macaques (Macaca fascicularis), African green monkeys (Chlorocebus aethiops), and Ferrets (Mustela putorius furo) as Large Animal Models for COVID-19.Comp Med. 2021 Oct 1;71(5):433-441. doi: 10.30802/AALAS-CM-21-000032. Epub 2021 Sep 29. Comp Med. 2021. PMID: 34588096 Free PMC article.
-
Animal models for COVID-19: advances, gaps and perspectives.Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8. Signal Transduct Target Ther. 2022. PMID: 35798699 Free PMC article. Review.
-
Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.Int Rev Immunol. 2024;43(1):13-32. doi: 10.1080/08830185.2022.2089666. Epub 2022 Jun 25. Int Rev Immunol. 2024. PMID: 35757923 Review.
-
Animal Models of COVID-19 II. Comparative Immunology.ILAR J. 2021 Dec 31;62(1-2):17-34. doi: 10.1093/ilar/ilab010. ILAR J. 2021. PMID: 33914873 Free PMC article. Review.
Cited by
-
Negative-Strand RNA Virus-Vectored Vaccines.Methods Mol Biol. 2024;2786:51-87. doi: 10.1007/978-1-0716-3770-8_3. Methods Mol Biol. 2024. PMID: 38814390 Review.
-
The glycosaminoglycan-binding chemokine fragment CXCL9(74-103) reduces inflammation and tissue damage in mouse models of coronavirus infection.Front Immunol. 2024 Apr 15;15:1378591. doi: 10.3389/fimmu.2024.1378591. eCollection 2024. Front Immunol. 2024. PMID: 38686377 Free PMC article.
-
Testing pulmonary physiology in ventilated non-human primates.J Med Primatol. 2024 Apr;53(2):e12694. doi: 10.1111/jmp.12694. J Med Primatol. 2024. PMID: 38454198
-
Dermatologic Changes in Experimental Model of Long COVID.Microorganisms. 2024 Jan 27;12(2):272. doi: 10.3390/microorganisms12020272. Microorganisms. 2024. PMID: 38399677 Free PMC article.
-
SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.Viruses. 2023 Nov 29;15(12):2341. doi: 10.3390/v15122341. Viruses. 2023. PMID: 38140582 Free PMC article.
References
-
- Bao L., Deng W., Huang B., Gao H., Liu J., Ren L., et al. . (2020). The Pathogenicity of SARS-CoV-2 in Hace2 Transgenic Mice. Nature 583 (7818), 830–833. - PubMed
-
- Barthold S. W., Smith A. L. (1983). Mouse Hepatitis Virus S in Weanling Swiss Mice Following Intranasal Inoculation. Lab. Anim. Sci. 33 (4), 355–360. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous